Coronary artery perforation is a rare but catastrophic complication of percutaneous coronary intervention (PCI). Grade III coronary perforation and rupture invariably results in pericardial effusion and tamponade requiring urgent pericardiocentesis. Advances in coronary intervention have increased the opportunity to treat coronary artery perforation. We are reporting a case of 55 years old hypertensive female who presented with effort angina. Coronary angiogram revealed significant stenosis in the left anterior descending coronary artery. Post PCI, she had Ellis type III coronary perforation and pericardial tamponade and cardiogenic shock. The patient was resuscitated, pericardiocentesis done, autologous blood transfusion given and covered stent deployed.
Introduction
Percutaneous coronary intervention (PCI) is now undoubtedly an indispensable option for the treatment of coronary artery disease (CAD). 1 Current advances in stenting technique have allowed interventional cardiologists to bail out most complications. Coronary perforation (CP) is still a dreaded complication of PCI. 2 Ellis type 3 rupture is especially associated with high morbidity and mortality; adequate and prompt treatment often amounting to the requirement for pericardiocentesis is essential to rescue such severe cases. 3 Here, we are reporting a case of Ellis type III CP of left anterior descending coronary artery (LAD) immediately following PCI with development of hypotension, pericardial tamponade and cardiac arrest. Patient was successfully resuscitated, perdiocardiocentesis done, autologous blood transfusion given and urgent implantation of a polytetrafluoroethylene (PTFE)-covered stent.
Case report
A 55-year-old female presented with effort angina of Canadian Cardiological Society (CCS) scale II for the last two months. She was obese and hypertensive without any history of diabetes.
Electrocardiogram was suggestive of left ventricular hypertrophy (LVH) with strain pattern. Echocardiogram showed concentric LVH with normal bi-ventricular function. Treadmill test was positive at 7.1 METS. She had undergone coronary angiogram (CAG) which revealed two tandem lesion of 90% stenosis in the mid segment of LAD ( Fig. 1; video 1 ) and right coronary has proximal total occlusion with retrograde filling from LAD. Due to her symptoms along with significant CAD, she was planned for PCI and stenting to LAD because the occlusion of the RCA appeared to be chronic and was adequately collateralised from the left system therefore it was planned to manage the LAD lesion as the first priority. A 3 Â 38 mm Zotarolimus eluting stent (Endeavor Resolute; Medtronic, Inc.) was deployed at 12 atm in LAD covering the two lesions after adequate pre-dilatation. The pressure used for the inflation was below the burst pressure recommended by the manufacturer for the stent. Immediately after stent deployment, she complained severe chest pain and became drowsy and dyspneic. The patient developed significant hypotension and bradycardia at that time. Immediately, cardio-pulmonary resuscitation (CPR) was started, she was intubated and put on mechanical ventilator. After putting her into mechanical ventilator, check CAG revealed an Ellis type III CP in the mid LAD (Fig. 2 , Video 2). Echocardiogram also confirmed the presence of large pericardial effusion with pericardial tamponade. So, immediate pericardiocentesis done and 250 ml of blood aspirated from the pericardial cavity. This blood had been given to her as autologous transfusion. At the same time, we had decided to close this perforation by using a PTFE covered stent. A 3.5 Â 16 mm Graftmaster covered stent (Abbott Vascular) was deployed at 12 atm in the mid LAD to close the perforation (Fig. 3, Video 3) . Post stent deployment, there was complete sealing of the CP. Later, proximal part of drug eluting stent (DES) and its overlapping part with covered stent were post dilated by using a non compliant (Sprinter RX, Medtronic) balloon at 14 atm. After post dilatation, there was TIMI III flow without any residual leak in the LAD (Fig. 4 , Video 4). Her vitals became stable after the procedure and she was extubated on the very next day and discharged 5 days after the procedure. Follow-up over last 6 months, she is doing well and without having any effort angina.
Supplementary video related to this article can be found online at http://dx.doi.org/10.1016/j.jcdr.2014.01.003.
Discussion
Grade III CP or coronary rupture although is extremely rare but well recognized complication of PCI. 4 Grade III CP is defined by the Ellis criteria as a perforation resulting in extravasation of blood 
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through a frank perforation (>1 mm) or spilling into an anatomic cavity. 5 The incidence of grades I to III coronary perforation range from 0.1% to 3.0%. 4 The key risk factors which are considered to predispose to the causation of perforation are advanced patient age, female gender and the use of ablative devices. 6 Grade III CP is the most serious form of perforation with a high incidence of mortality rates which may range from 7% to 44% of cases. It is also associated with very high rates of cardiac tamponade which may be as high as 40% and the need for emergency coronary artery bypass grafting (CABG) ranges between 20% and 40%. 7 Type 1 and 2 perforations are predominately caused by hydrophilic and stiff wires and the course of these is usually mildly symptomatic and does not require pericardial drainage or surgical intervention. 8 Type 3 perforations are more often associated with stent placement by over dilatation or oversized stent placement as might be the cause in our case or during aggressive usage of athero-ablative devices. Most cases of grade III CP can be managed with percutaneous methods. 7 Treatment modalities include prolonged balloon inflation, PTFE covered stent implantation with or without the requirement of pericardiocentesis for cardiac tamponade. Rare cases may require an emergency CABG and microcoil embolization. Reversal of heparin anticoagulant antiglycoprotein IIb/IIIa inhibitors (GPI) activity is often required as a part of the therapeutic strategy. 9 Often a combination of these techniques is required to achieve adequate hemostasis. Newer techniques such as covered stent deployment have led to a decrease in the requirement of emergency CABG. 9 The incidence of CP with a higher proportion of grade III perforation appears to be increasing because of higher rates of PCI in complex patient and lesion subgroups and the aggressive usage of atheroablative strategies with the widespread use of GP IIb-IIIa inhibitors. 10, 11 Though covered stent have been reported to increase thrombogenicity, there are now several reports of the use of covered stents to seal CP with good and lasting results. 5, 6 This strategy is more effective if the perforation is located in the proximal or mid-portion of the index vessel and the guidewire is correctly positioned distally in the true lumen. 6 In our case, though we had deployed the stent at a high pressure but the pressure was lower than the burst pressure recommended by the manufacturer and it seemed that oversizing of stent was the cause CP as the index vessel diameter was probably less than 3 mm. We performed immediate resuscitation, urgent pericardiocentesis, autologous transfusion and immediate covered stenting with a PTFE stent to close the perforation which eventually proved to be successful in the management of CP in our case. The activated clotting time in our case was 225 s and injection of protamine was not given to revert the anticoagulant action of heparin as performed immediate stenting to seal the perforation. Though patient was intubated and put on mechanical ventilator to tide over the crisis period but her vitals became stable after covered stenting. Finally, she was successfully extubated on next day and discharged 5 days after admission.
Conclusion
Though grade III CP is a dramatic, dreaded and lethal complication of PCI but it can be managed successfully by immediate diagnosis and prompt treatment which involves sealing of the perforation by a covered stent. 
